Global Hepatitis Community
  • Home
  • About Us
  • News
  • Video
  • Congresses
  • Book&Brochure
  • Hope Health Club
  • Gallery
  • Consultant Committee
  • Contact Us
  • Search
  • Menu
  • Twitter
  • Facebook

News

You are here: Home / News

Recent Posts

  • PharMEdent 2019
  • An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.
  • Real-world effectiveness and safety of sofosbuvir/velpatasvir and ledipasvir/sofosbuvir hepatitis C treatment in a single centre in Germany.

Where to find us

NO.178, Shadab Cross, Sepahbod Gharani St., Tehran, Iran.

+98-21-81262072

Instagram

Follow Me!

Our Office Hours

Sa-We: 8:00-14:00Sa: 8:00-14:00
Th-Fr: closed

Design by : Meisam Fathi
  • Terms of Service
  • Legal notice
Scroll to top